Table 2.

Antienteropooling effects of C. abyssinica extract and solvent fractions.

Treatment given		VSIC (ml)	% inhibition in volume	WSIC (g)	% inhibition in weight
Negative control		0.86 ± 0.03	—	0.91 ± 0.03	—
Extract (mg/kg)	100	0.74 ± 0.03e∗∗∗	14.48	0.80 ± 0.03e∗∗	11.56
	200	0.62 ± 0.03e∗∗	28.18	0.73 ± 0.02e∗	19.44
	400	0.47 ± 0.02a∗∗	45.74	0.50 ± 0.02a∗	45.42
Solvent fractions (mg/kg)	CF 100	0.68 ± 0.05e∗∗∗	10.23	0.78 ± 0.09e∗∗	25.50
	CF 200	0.47 ± 0.33a∗∗	25.09	0.65 ± 0.05	48.44
	CF 400	0.39 ± 0.04a∗∗∗b∗	47.68	0.45 ± 0.121a∗	56.88
	n-BF 100	0.67 ± 0.06e∗∗∗	20.65	0.69 ± 0.13	26.60
	n-BF 200	0.43 ± 0.03a∗∗∗b∗	50.39	0.49 ± 0.03a∗	45.87
	n-BF 400	0.35 ± 0.08a∗∗∗b∗∗	51.73	0.42 ± 0.09a∗∗	61.47
	AF 100	0.55 ± 0.08a∗e∗	33.20	0.58 ± 0.12	39.45
	AF 200	0.50 ± 0.12a∗∗	41.70	0.51 ± 0.10	44.40
	AF 400	0.33 ± 0.10a∗∗∗b∗∗	43.24	0.49 ± 0.09a∗	63.86
Positive control		0.20 ± 0.07a∗∗∗b∗∗∗	65.25	0.30 ± 0.11a∗∗∗b∗∗	77.98

Values are expressed as mean ± SEM (n=6); analysis was performed using one-way ANOVA followed by Tukey's post hoc test; ^acompared to negative control, ^bcompared to 100 mg/kg crude extract, ^ccompared to 200 mg/kg crude extract, ^dcompared to 400 mg/kg crude extract, ^ecompared to positive control. ^∗p < 0.05; ^∗∗p < 0.01; ^∗∗∗p < 0.001. CF = chloroform fraction; n-BF = n-butanol fraction; AF = aqueous fraction; VSIC = volume of small intestinal content; WSIC = weight of small intestinal content.